For Investors

Press Releases

ReWalk Robotics to Report First Quarter 2019 Financial Results on May 7, 2019

05/03/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , May 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2019 financial results on Tuesday, May 7, 2019 , before the U.S.

ReWalk Robotics Regains Compliance with Nasdaq Listing Rules 5550(a) and 5550(b)

04/26/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 26, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has regained compliance with Nasdaq Listing Rules 5550(b) (“Rule 5550(b)”) and 5550(a)(2) (“Rule 5550(a)(2)”).

ReWalk Announces Regional Blue Cross Blue Shield Plan Beneficiaries Are Winning Requests to Walk Again

04/25/19

Independent reviewer authorizes coverage of ReWalk system for another paralyzed individual, the 17th by a regional BCBS plan MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 25, 2019 /PRNewswire/ -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that an

ReWalk Robotics to Present at the ThinkEquity Conference on May 2nd

04/23/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , April 23, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski , Chief Executive Officer and Andy Dolan , Vice President of Marketing, will present at the ThinkEquity Conference in

ReWalk Announces First Personal Exoskeleton Provided to Cigna Beneficiary

04/16/19

Reimbursement of the device marks a key milestone in the Company's relationship with major U.S. private insurers. MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , April 16, 2019 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that the first Cigna

ReWalk Robotics Announces Closing of Registered Direct Offering for $4.25 Million Priced At-the-Market

04/05/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 816,914 ordinary shares at a purchase price of $5.2025

ReWalk Robotics Announces Pricing of Registered Direct Offering for $4,250,000

04/03/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 816,914 ordinary

ReWalk Robotics Completes One-for-Twenty-Five Reverse Share Split

03/29/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , March 29, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.  (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) reported today that it has completed the reverse share split of ReWalk ordinary share at a ratio of one-for-twenty-five shares, which will take

ReWalk Robotics Announces Closing of $4.37 Million Public Offering

02/25/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 25, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the closing and funding of its previously announced public offering of 19,000,000 ordinary shares at a price to the public of $0.23 per

ReWalk Robotics Announces Pricing of $4.37 Million Public Offering of Ordinary Shares

02/21/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 21, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the pricing of a public offering of 19,000,000 ordinary shares, offered at a price to the public of $0.23 per share, for gross proceeds

ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares

02/20/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 20, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced that it intends to offer and sell, subject to market and other conditions, its ordinary shares in a public offering. The offering is

ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation

02/19/19

Innovation in robotic rehabilitation technology will provide the first-of-its-kind medical device to rehab clinics nationwide, to treat the millions of patients with lower limb disability due to stroke MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Feb.